According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are A$15.99 Million. In 2024 the company made an earning of -A$51.2 Million a decrease over its 2023 earnings that were of -A$16.49 Million. The earnings displayed on this page is the company's Pretax Income.